Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors

Clinical trial NCT02429466 · COMPLETED

Trial details

NCT number: NCT02429466
Sponsor: Nasser Hanna
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Germ Cell Tumor Testis Cancer Testicular Cancer

Start date: 2015-04-27
Primary completion: 2018-06-04
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.